- Tell us: How are you planning to afford GLP-1 drugs? The Boston Globe
- Weight-loss drugs are already dropping in price; could they go even lower? The Independent
- Employers Still Reluctant To Cover Obesity Meds, But Lower Costs May Change This Forbes
- The MAHA agenda won’t include expanding GLP-1 coverage — for now Pharma Voice
- GLP-1 Pricing ‘Paradigm Shift’ Possible, But Would It Meet Trump’s MFN Goals? insights.citeline.com